2026-07-06 Neurocrine Biosciences Inc

Share Article

The stock price moved lower in early trading and attempted to rebound during the session. Unfortunately, it was still unable to close above yesterday’s closing price, so I sold part of my position to reduce risk.

You might also like

Strategy 1

Strategy 1 US Value Stock Screener: Average Volume 30 Day > 20M Price x Volume > 10M Market Cap >= 200 B Price >= $20

2026-04-28 Ventas, Inc.

Bought Ventas, Inc. as it somewhat meets Strategy 1 criteria.The stock has been either consolidating sideways or in a short-term downtrend. 👍 Positives MACD has